HSBC Holdings’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.6K | Sell |
25,157
-330
| -1% | -$467 | ﹤0.01% | 2481 |
|
|
2025
Q1 | $41.3K | Buy |
25,487
+6,128
| +32% | +$9.93K | ﹤0.01% | 2471 |
|
|
2024
Q4 | $68.3K | Sell |
19,359
-1,809
| -9% | -$6.39K | ﹤0.01% | 2521 |
|
|
2024
Q3 | $123K | Buy |
+21,168
| New | +$123K | ﹤0.01% | 2376 |
|
|
2024
Q1 | – | Sell |
-30,200
| Closed | -$171K | – | 2618 |
|
|
2023
Q4 | $171K | Sell |
30,200
-2,453
| -8% | -$13.9K | ﹤0.01% | 2044 |
|
|
2023
Q3 | $62K | Hold |
32,653
| – | – | ﹤0.01% | 2099 |
|
|
2023
Q2 | $90.3K | Buy |
32,653
+13,893
| +74% | +$38.4K | ﹤0.01% | 2006 |
|
|
2023
Q1 | $60.1K | Buy |
18,760
+8,605
| +85% | +$27.6K | ﹤0.01% | 2116 |
|
|
2022
Q4 | $58.9K | Buy |
+10,155
| New | +$58.9K | ﹤0.01% | 2465 |
|
|
2022
Q2 | – | Sell |
-10,275
| Closed | -$251K | – | 2805 |
|
|
2022
Q1 | $251K | Buy |
+10,275
| New | +$251K | ﹤0.01% | 2499 |
|